SDEV Stablecoin Development Corp

CIK 0001389545 44 ready 8-Ks latest May 20, 2026, 8:38 AM ET RSS · JSON

Activity: NORMAL 1 filings / 30d vs 2 baseline Risk accumulating: auditor change (2)

Ready 8-Ks 44

Latest filing May 20, 2026, 8:38 AM ET

Top materiality 1.00

Event mix other_material ×28 · m_and_a ×7 · earnings ×2

Sentiment 10 pos · 15 neg · 19 neu

Latest earnings reported 2026-Q1

Recent 8-K filings for SDEV

Highest-materiality recent filing

NovaBay to rename Stablecoin Development Corp; holds 2.06B SKY tokens (8.78% of supply)

March 23, 2026, 7:59 PM ET other material materiality 1.00 positive item 2.02 item 7.01 item 8.01 item 9.01

Name change to Stablecoin Development Corporation; ticker changes from NBY to SDEV effective Apr 3, 2026.
Holds approx. 2.06 billion SKY tokens (~8.78% of total supply) as of March 16, 2026.

Read filing →

May 20, 2026, 8:38 AM ET earnings materiality 0.70 positive item 2.02 item 7.01 item 9.01

SDEV Q1 2026 operating income $22.3M vs loss $3.3M YoY; GAAP net income $552.4M driven by non-cash warrant gains

Operating income of $22.3 million vs operating loss of $3.3 million in Q1 2025; staking revenue $2.5M, unrealized gain on digital assets $22.7M.
April 29, 2026, 7:59 PM ET other material materiality 0.95 negative item 4.02 ◈ Auditor Changes

SDEV restates 2025 financials; warrant error increases net loss from $22.1M to $630.8M

Audit committee concludes 2025 financials non-reliable due to pre-funded warrant accounting error.
April 6, 2026, 7:59 PM ET other material materiality 0.60 neutral item 2.02 item 9.01

Stablecoin Dev Corp trades on NYSE American under SDEV; holds 2.15B SKY tokens (9.15% supply)

Name change to Stablecoin Development Corp effective April 2; ticker changed to SDEV.
April 1, 2026, 7:59 PM ET other material materiality 0.60 positive item 5.02 item 5.03 item 9.01 ◈ Governance Changes ×2

NovaBay shareholders approve 2026 equity plan; CEO gets ~19.6M RSUs/PSUs; name change to Stablecoin Development Corp

Stockholders approved 2026 Equity Incentive Plan on March 12, 2026, authorizing 22,223,927 initial shares plus annual increases.
March 23, 2026, 7:59 PM ET other material materiality 1.00 positive item 2.02 item 7.01 item 8.01 item 9.01

NovaBay to rename Stablecoin Development Corp; holds 2.06B SKY tokens (8.78% of supply)

Name change to Stablecoin Development Corporation; ticker changes from NBY to SDEV effective Apr 3, 2026.
March 12, 2026, 7:59 PM ET other material materiality 0.70 neutral item 5.03 item 5.07 item 9.01 ◈ Governance Changes

NovaBay shareholders approve 5B authorized shares, officer exculpation, and 2026 equity plan

Authorized common stock increased from 1.5B to 5B shares; prohibition on stockholder action by written consent removed.
February 20, 2026, 6:59 PM ET other material materiality 0.60 neutral item 3.03 item 5.03 item 9.01 ◈ Governance Changes

NovaBay Pharmaceuticals effects 1-for-5 reverse stock split

Reverse stock split effective at 4:15 p.m. ET on Feb 20, 2026; trading on split-adjusted basis from Feb 23.
February 12, 2026, 6:59 PM ET other material materiality 0.60 neutral item 8.01 item 9.01

NovaBay announces 1-for-5 reverse stock split effective Feb 20, 2026

Reverse split ratio 1-for-5; effective after market close on Feb 20, trading on split-adjusted basis Feb 23.
January 28, 2026, 6:59 PM ET other material materiality 0.70 negative item 4.01 item 9.01

NovaBay auditor Withum declines re-appointment; dissolution plan noted in prior audit

WithumSmith+Brown declined to stand for re-appointment as auditor for FY2025 as of Jan 22, 2026.
January 20, 2026, 6:59 PM ET other material materiality 0.75 neutral item 1.01 item 9.01 ◈ Material Agreements

NovaBay enters $100M ATM equity distribution agreement with Virtu Americas LLC

Company may sell up to $100M of common stock from time to time through Virtu as sales agent.
January 16, 2026, 6:59 PM ET other material materiality 0.90 neutral item 1.01 item 3.02 item 8.01 item 9.01 ◈ Material Agreements

NovaBay raises $134M via pre-funded warrants, pivots to digital asset strategy focused on SKY tokens

Issued pre-funded warrants for 837.7M shares at $0.17/warrant, gross proceeds ~$134M.
October 20, 2025, 7:59 PM ET M&A materiality 0.80 neutral item 1.01 item 3.02 item 3.03 item 5.01 item 5.02 item 5.03 item 5.07 item 9.01 ◈ Governance Changes◈ M&A Transactions

NovaBay: Change of control as R01/Framework each own 45.1%; new CEO; reverse split approved

R01 Fund LP and Framework Ventures IV each beneficially own 45.1% of outstanding common stock post-conversion.
October 9, 2025, 7:59 PM ET leadership materiality 0.85 negative item 5.02 item 8.01

CEO David Lazar resigns; R01 and Framework to buy preferred shares, gaining ~90% ownership

CEO David Lazar resigned effective upon release of escrow funds from a securities purchase agreement.
August 26, 2025, 7:59 PM ET dividend materiality 0.60 positive item 8.01 item 9.01

NovaBay declares $0.80 special dividend; record date Sep 15, pay date Sep 29

Special cash dividend of $0.80 per common share declared by Board and Special Transaction Committee.
August 19, 2025, 7:59 PM ET M&A materiality 0.85 neutral item 1.01 item 5.02 item 5.03 item 3.02 item 3.03 item 8.01 item 9.01 ◈ Governance Changes

NovaBay sells ~95% of diluted shares to David Lazar for $6M; names him CEO; plans special dividend

Lazar purchased 481,250 Series D preferred shares for $3.85M at First Closing; will buy 268,750 Series E shares for $2.15M later.
April 22, 2025, 7:59 PM ET other material materiality 0.90 negative item 5.07

NovaBay shareholders approve liquidation and dissolution plan

Proposal to dissolve company passed with 3,080,743 votes for, 42,531 against, 228 abstain.
March 11, 2025, 7:59 PM ET other material materiality 0.70 neutral item 1.01 item 9.01

NovaBay settles warrant disputes with Sabby, Bigger, District 2; secures voting support for dissolution

Sabby settlement: exercises 263,892 warrants at $0.66/share; company buys back remaining 1,008,834 warrants for $1.125M.
March 7, 2025, 6:59 PM ET other material materiality 0.75 negative item 1.01 item 8.01 item 9.01

NovaBay sets April 16 special meeting for dissolution vote; hires Lucid Capital for alternatives

Special meeting on April 16, 2025; record date March 18, 2025. Stockholders to vote on complete liquidation/dissolution.
February 4, 2025, 6:59 PM ET other material materiality 0.75 neutral item 5.07 item 8.01 item 9.01

NovaBay shareholders reject liquidation proposal; board plans new vote

On Jan 30, 2025, stockholders voted down Proposal Two (liquidation/dissolution); 49% of outstanding shares voted for, below the required >50%.
January 23, 2025, 6:59 PM ET other material materiality 0.90 negative item 2.01 item 5.07 item 8.01 item 5.02 item 9.01

NovaBay completes $11.5M Avenova asset sale; dissolution vote adjourned to Jan 30

Closed sale of Avenova eyecare business to PRN for $11.5M cash, net of $507,954 bridge loan payoff and $500K escrow.
January 10, 2025, 6:59 PM ET other material materiality 0.65 negative item 1.01 item 2.01 item 9.01

NovaBay sells wound care trademarks and inventory for $626,000 to Phase One Health LLC

Sold NeutroPhase, PhaseOne, OmniPhase trademarks for $500,000 to Phase One Health LLC.
December 19, 2024, 6:59 PM ET other material materiality 0.80 negative item 5.07 item 8.01 item 9.01

NovaBay special meeting adjourned again; asset sale and dissolution votes still short of needed 50% threshold

Special meeting reconvened Dec 18, 2024 adjourned to Jan 16, 2025 due to insufficient votes.
November 22, 2024, 6:59 PM ET other material materiality 0.80 negative item 5.07 item 8.01 item 9.01

NovaBay adjourns special meeting on asset sale and dissolution; insufficient votes, reconvenes Dec 18

Special meeting Nov 22: only 43% of shares represented, insufficient votes for 50% threshold.
November 6, 2024, 6:59 PM ET M&A materiality 0.70 neutral item 1.01 item 2.03 item 8.01 item 9.01

NovaBay revises Avenova sale to PRN; base price upped to $11.5M, bridge loan secured

Base purchase price for Avenova assets increased from $9.5M to $11.5M.
October 29, 2024, 7:59 PM ET other material materiality 0.75 positive item 8.01 item 9.01

NovaBay receives superior offer from Refresh Acquisitions for Avenova at $11.5M

Refresh offers $11.5M base purchase price for Avenova assets, vs $9.5M from PRN.
October 16, 2024, 7:59 PM ET other material materiality 0.90 negative item 2.02 item 7.01

NovaBay reports $776K cash as of Sept 30; sets Nov 22 special meeting for asset sale and dissolution

Preliminary unaudited cash and cash equivalents of $776,000 as of September 30, 2024.
September 20, 2024, 7:59 PM ET M&A materiality 1.00 negative item 1.01 item 8.01 item 2.05 item 7.01 item 9.01

NovaBay to sell Avenova brand for $9.5M to PRN; plans dissolution

NovaBay signs definitive agreement to sell Avenova assets to PRN for $9.5M cash; closing expected Q4 2024.
July 29, 2024, 7:59 PM ET debt materiality 0.75 positive item 1.01 item 8.01 item 9.01

NovaBay raises ~$3.87M in public offering to redeem convertible debentures due Nov 2024

Gross proceeds $3.87M; offering included 1.16M shares, 2.04M pre-funded warrants, and 3.54M each of Series F-1/F-2/F-3 warrants.
July 11, 2024, 7:59 PM ET earnings materiality 0.60 positive item 2.02 item 7.01 item 9.01

NovaBay reports prelim Q2 2024 net revenue $2.4M; eyecare revenue up 9% YoY

Preliminary Q2 2024 net revenue of $2.4M; H1 2024 net revenue $5.0M.
June 7, 2024, 7:59 PM ET other material materiality 0.65 positive item 3.01 item 9.01

NovaBay gets NYSE American acceptance of compliance plan; trading continues with .BC indicator

NYSE American accepted plan on June 4, 2024; plan period runs through October 18, 2025.
May 31, 2024, 7:59 PM ET other material materiality 0.70 neutral item 9.01

NovaBay reports pro forma Q1 2024 net loss $2.3M after DERMAdoctor sale; 1:35 reverse split

Pro forma Q1 2024: product revenue $2.6M, net loss from cont. ops $2.3M (vs historical $3.1M).
May 31, 2024, 7:59 PM ET other material materiality 0.65 negative item 3.03 item 5.03 item 9.01

NovaBay effect 1-for-35 reverse stock split effective May 30, 2024

Reverse stock split at 1-for-35 ratio; effective 4:15 p.m. ET on May 30, 2024.
May 29, 2024, 7:59 PM ET other material materiality 0.75 negative item 3.01 item 5.07 item 8.01 item 9.01

NovaBay receives additional NYSE non-compliance notice; approves 1-for-35 reverse split

Stockholders' equity $160k as of March 31, below $2M minimum; delisting risk if not cured by Oct 2025.
April 19, 2024, 7:59 PM ET regulatory materiality 0.75 negative item 3.01 item 8.01 item 9.01 ◈ Listing & Compliance Notices

NovaBay receives NYSE American delisting notice for insufficient stockholders' equity

Stockholders' equity was $3.3M as of Dec 31, 2023, below $4M and $6M thresholds.
March 25, 2024, 7:59 PM ET M&A materiality 0.70 neutral item 1.01 item 3.02 item 9.01

NovaBay sells DERMAdoctor for $1.07M; issues warrants/notes to secured parties as consent

Sale of DERMAdoctor to New Age Investments LLC for $1.07M, expected to close March 25, 2024.
March 14, 2024, 7:59 PM ET M&A materiality 0.75 negative item 1.01 item 2.02 item 9.01 ◈ Earnings Releases◈ Material Agreements

NovaBay sells DERMAdoctor skincare for $1.07M; reports Q4 net sales $3.7M, operating loss $3.2M

Sells DERMAdoctor for ~$1.07M cash to New Age Investments; closing expected by March 31, 2024.

Earnings & guidance

2026-Q1 EPS reported $3.33 filing →

Materiality & sentiment trend

Max materiality 1.00 · Median 0.70 · Most common event other_material

10 positive 15 negative 19 neutral

source · SDEV on sec.gov